Literature DB >> 11576222

Evidence of the extrathymic development of tyrosinase-related protein-2-recognizing CD8+ T cells with low avidity.

M Harada1, H Yamada, K Tatsugami, K Nomoto.   

Abstract

The majority of the human tumour-associated antigens characterized to date are derived from non-mutated self-proteins. However, nothing is known about the development of autoreactive and tumour-associated antigen-recognizing T cells. Tyrosinase-related protein (TRP)-2 is a non-mutated melanocyte differentiation antigen and TRP-2-recognizing CD8+ T cells are known to show responses to melanoma both in humans and mice. In addition, TRP-2-reactive T cells with low avidity have been suggested to be readily induced from the spleen cells of naïve mice. On the other hand, recent reports suggest that self antigen-reactive CD8+ T cells can be positively selected in the periphery. In this study, we tested the possibility that TRP-2-reactive CD8+ T cells in naïve mice could develop via the extrathymic pathway. As a consequence, TRP-2-reactive CD8+ T cell precursors in naïve C57BL/6 mice were suggested to express both interleukin-2 (IL-2) receptor beta chain (IL-2Rbeta) and CD44 molecules, in a manner similar to that of extrathymically developed T cells. Furthermore, IL-2Rbeta+ CD44+ CD8+ T cells were detected in the adult thymectomized and bone marrow-reconstituted mice, and functional TRP-2-reactive T cells were generated from their spleen cells. Overall, these results suggest that low avidity CD8+ T cells recognizing TRP-2 can be developed extrathymically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576222      PMCID: PMC1783276          DOI: 10.1046/j.1365-2567.2001.01278.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells.

Authors:  H Watanabe; C Miyaji; Y Kawachi; T Iiai; K Ohtsuka; T Iwanage; H Takahashi-Iwanaga; T Abo
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

2.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Authors:  M A Alexander-Miller; G R Leggatt; A Sarin; J A Berzofsky
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

3.  Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.

Authors:  Y Kawakami; S Eliyahu; C Jennings; K Sakaguchi; X Kang; S Southwood; P F Robbins; A Sette; E Appella; S A Rosenberg
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

4.  Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors.

Authors:  R E Toes; R J Blom; R Offringa; W M Kast; C J Melief
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

5.  Characterization of B16 melanoma-specific cytotoxic T lymphocytes.

Authors:  M Harada; K Tamada; K Abe; T Li; Y Onoe; H Tada; K Tatsugami; T Ando; G Kimura; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1998-12       Impact factor: 6.968

6.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; K Sakaguchi; E Appella; J R Yannelli; G J Adema; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

7.  Cancer antigens: immune recognition of self and altered self.

Authors:  A N Houghton
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

8.  Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).

Authors:  D J Loftus; C Castelli; T M Clay; P Squarcina; F M Marincola; M I Nishimura; G Parmiani; E Appella; L Rivoltini
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation.

Authors:  K Sato; K Ohtsuka; K Hasegawa; S Yamagiwa; H Watanabe; H Asakura; T Abo
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  V Brichard; A Van Pel; T Wölfel; C Wölfel; E De Plaen; B Lethé; P Coulie; T Boon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  1 in total

1.  Inhibitory effect of live-attenuated Listeria monocytogenes-based vaccines expressing MIA gene on malignant melanoma.

Authors:  Yue Qian; Na Zhang; Ping Jiang; Siyuan Chen; Shujuan Chu; Firas Hamze; Yan Wu; Qin Luo; Aiping Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.